Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(30%)
Results Posted
100%(4 trials)

Phase Distribution

Ph not_applicable
4
40%
Ph phase_4
1
10%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(4)
Other(2)

Detailed Status

Completed4
Recruiting3
unknown2
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (20.0%)
N/A4 (80.0%)

Trials by Status

enrolling_by_invitation110%
completed440%
recruiting330%
unknown220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DEVICE
Total Trials
10